Keum YS - Search Results

1

Chemopreventive functions of isothiocyanates.

Keum YS, Jeong WS, Kong AN. Keum YS, et al. Drug News Perspect. 2005 Sep;18(7):445-51. doi: 10.1358/dnp.2005.18.7.939350. Drug News Perspect. 2005. PMID: 16362084 Free article. Review.

2

Involvement of Nrf2 and JNK1 in the activation of antioxidant responsive element (ARE) by chemopreventive agent phenethyl isothiocyanate (PEITC).

Keum YS, Owuor ED, Kim BR, Hu R, Kong AN. Keum YS, et al. Pharm Res. 2003 Sep;20(9):1351-6. doi: 10.1023/a:1025737622815. Pharm Res. 2003. PMID: 14567627

3

Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms.

Keum YS, Jeong WS, Kong AN. Keum YS, et al. Mutat Res. 2004 Nov 2;555(1-2):191-202. doi: 10.1016/j.mrfmmm.2004.05.024. Mutat Res. 2004. PMID: 15476860 Review.

4

Differential expression and stability of endogenous nuclear factor E2-related factor 2 (Nrf2) by natural chemopreventive compounds in HepG2 human hepatoma cells.

Jeong WS, Keum YS, Chen C, Jain MR, Shen G, Kim JH, Li W, Kong AN. Jeong WS, et al. Among authors: keum ys. J Biochem Mol Biol. 2005 Mar 31;38(2):167-76. doi: 10.5483/bmbrep.2005.38.2.167. J Biochem Mol Biol. 2005. PMID: 15826493

5

ERK and JNK signaling pathways are involved in the regulation of activator protein 1 and cell death elicited by three isothiocyanates in human prostate cancer PC-3 cells.

Xu C, Shen G, Yuan X, Kim JH, Gopalkrishnan A, Keum YS, Nair S, Kong AN. Xu C, et al. Among authors: keum ys. Carcinogenesis. 2006 Mar;27(3):437-45. doi: 10.1093/carcin/bgi251. Epub 2005 Nov 4. Carcinogenesis. 2006. PMID: 16272172

6

Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin.

Kim JH, Xu C, Keum YS, Reddy B, Conney A, Kong AN. Kim JH, et al. Among authors: keum ys. Carcinogenesis. 2006 Mar;27(3):475-82. doi: 10.1093/carcin/bgi272. Epub 2005 Nov 19. Carcinogenesis. 2006. PMID: 16299382

7

Combined inhibitory effects of curcumin and phenethyl isothiocyanate on the growth of human PC-3 prostate xenografts in immunodeficient mice.

Khor TO, Keum YS, Lin W, Kim JH, Hu R, Shen G, Xu C, Gopalakrishnan A, Reddy B, Zheng X, Conney AH, Kong AN. Khor TO, et al. Among authors: keum ys. Cancer Res. 2006 Jan 15;66(2):613-21. doi: 10.1158/0008-5472.CAN-05-2708. Cancer Res. 2006. PMID: 16423986

8

Butylated hydroxyanisole regulates ARE-mediated gene expression via Nrf2 coupled with ERK and JNK signaling pathway in HepG2 cells.

Yuan X, Xu C, Pan Z, Keum YS, Kim JH, Shen G, Yu S, Oo KT, Ma J, Kong AN. Yuan X, et al. Among authors: keum ys. Mol Carcinog. 2006 Nov;45(11):841-50. doi: 10.1002/mc.20234. Mol Carcinog. 2006. PMID: 16739127

9

Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells.

Keum YS, Yu S, Chang PP, Yuan X, Kim JH, Xu C, Han J, Agarwal A, Kong AN. Keum YS, et al. Cancer Res. 2006 Sep 1;66(17):8804-13. doi: 10.1158/0008-5472.CAN-05-3513. Cancer Res. 2006. PMID: 16951197

10

Pharmacogenomics of phenolic antioxidant butylated hydroxyanisole (BHA) in the small intestine and liver of Nrf2 knockout and C57BL/6J mice.

Nair S, Xu C, Shen G, Hebbar V, Gopalakrishnan A, Hu R, Jain MR, Lin W, Keum YS, Liew C, Chan JY, Kong AN. Nair S, et al. Among authors: keum ys. Pharm Res. 2006 Nov;23(11):2621-37. doi: 10.1007/s11095-006-9099-x. Epub 2006 Sep 13. Pharm Res. 2006. PMID: 16969697

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

186 results

Search Page

Filters